RELEVATE HEALTH GAMES, LLC – Trademark Portfolio
Entity Type: 16
RELEVATE HEALTH GAMES, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include LEVEL EX, TOP DERM, TD TOP DERM, and LEVEL EX GAMES. The owner is based in CINCINNATI, OH.
8044 MONTGOMERY ROAD
SUITE 700
CINCINNATI, OH 45236
Showing of trademarks Trademarks
Trademark Classifications
RELEVATE HEALTH GAMES, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does RELEVATE HEALTH GAMES, LLC have?
RELEVATE HEALTH GAMES, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does RELEVATE HEALTH GAMES, LLC file in?
RELEVATE HEALTH GAMES, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are RELEVATE HEALTH GAMES, LLC's most well-known trademarks?
RELEVATE HEALTH GAMES, LLC's registered trademark portfolio includes well-known marks such as LEVEL EX, TOP DERM, TD TOP DERM, and LEVEL EX GAMES. These are among 4 currently registered trademarks in the portfolio.
What is RELEVATE HEALTH GAMES, LLC's trademark registration success rate?
RELEVATE HEALTH GAMES, LLC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.